A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects

Clinical trial NCT02431247 · COMPLETED

Trial details

NCT number: NCT02431247
Sponsor: Janssen Sciences Ireland UC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immunodeficiency Virus Type 1, Human

Start date: 2015-07-06
Primary completion: 2017-03-02
Enrollment: 725

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.